PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Researchers model familial amyloidosis in vitro using iPSC technology

2013-10-31
(Press-News.org) Contact information: Gina DiGravio
gina.digravio@bmc.org
617-638-8480
Boston University Medical Center
Researchers model familial amyloidosis in vitro using iPSC technology (Boston) -- Researchers from Boston University School of Medicine (BUSM) and Boston Medical Center (BMC) have generated the first known disease-specific induced pluripotent stem cell (iPSC) lines from a patient with familial transthyretin amyloidosis (ATTR). The findings, which are reported in Stem Cell Reports, may lead to new treatments for genetic diseases such as familial amyloidosis.

iPSCs are a form of stem cells that come from skin or blood cells reprogrammed into cells that have the ability to become any type of tissue in the body. ATTR is a lethal, autosomal dominant protein-folding disorder caused by one of more than 100 distinct mutations in the transthyretin (TTR) gene. In ATTR, protein secreted from the liver aggregates and forms fibrils in target organs, chiefly the heart and peripheral nervous system, highlighting the need for a model capable of duplicating the multisystem complexity of this clinically variable disease.

According to researchers using iPSC technology, cell lines can be established that are genetically identical to the individual from whom they are derived, allowing for disease modeling and development of novel therapeutics in the personalized genetic context of the patient from which they are made.

In this study, the researchers used the iPSC to generate liver cells that secrete the disease-specific mutant protein as well as cardiac and neuronal cells, the downstream target tissues of the disease. Upon exposure to the mutant protein, the heart and neuronal cells displayed signs of stress and an increased level of cell death as compared to those exposed to normal protein, thereby recreating essential aspects of the disease in vitro. Furthermore, small molecule stabilizers of the mutant protein that are being tested in clinical trials show efficacy in this model, validating this iPSC-based, patient-specific in vitro system as a platform for testing therapeutic strategies.

"Our work demonstrates that it is possible to model a complex, multisystem genetic disease in a relatively short space of time, using lineage-specified cells derived from patient stem cells," explained George J. Murphy, PhD, assistant professor of medicine in the section of Hematology and Oncology and co-director of the Center for Regenerative Medicine (CReM) at BUSM and BMC.

"This is a major breakthrough that will facilitate testing novel targeted therapies that are being developed for ATTR amyloidosis," said coauthor John Berk, MD, clinical director of the Amyloidosis Center at BUSM and BMC, where these rare diseases have been studied for more than 50 years. "Patients and families from all over the world who come to us for treatment may soon benefit from this research."

### Funding for the study was provided by the Amyloidosis Foundation, the Young Family Amyloid Research Fund and the Boston University Clinical and Translational Science Institute.


ELSE PRESS RELEASES FROM THIS DATE:

Study gives Catholic schools poor marks

2013-10-31
Study gives Catholic schools poor marks EAST LANSING, Mich. — A national study led by a Michigan State University economist suggests Catholic schools are not superior to public schools after all. Math scores for Catholic students dropped between kindergarten and eighth ...

Suzaku study points to early cosmic 'seeding'

2013-10-31
Suzaku study points to early cosmic 'seeding' Most of the universe's heavy elements, including the iron central to life itself, formed early in cosmic history and spread throughout the universe, according to a new study of the Perseus Galaxy Cluster ...

Researchers discover how retinal neurons claim the best brain connections

2013-10-31
Researchers discover how retinal neurons claim the best brain connections Discovery may shed light on brain disease, development of regenerative therapies Real estate agents emphasize location, location, and – once more for good measure – location. It's the same in a developing brain, ...

Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex

2013-10-31
Simple plants aren't always easy: Revision of the liverwort Radula buccinifera complex The supposedly widespread and variable Australasian liverwort species Radula buccinifera is nothing of the kind. The species was described in 1844, and reported for New Zealand in 1855. ...

Danish research provides new knowledge about the body's fight against HIV

2013-10-31
Danish research provides new knowledge about the body's fight against HIV When a person is infected with HIV the virus infects the cells of the immune system. From here the virus spreads around the body, while at the same time breaking down important ...

Patient in 'vegetative state' not just aware, but paying attention

2013-10-31
Patient in 'vegetative state' not just aware, but paying attention Research raises possibility of devices in the future to help some patients in a vegetative state interact with the outside world A patient in a seemingly vegetative state, unable to move or ...

Defective nanotubes turned into light emitters

2013-10-31
Defective nanotubes turned into light emitters UPV/EHU-University of the Basque Country researchers have developed and patented a new source of light emitter based on boron nitride nanotubes and suitable for developing high-efficiency optoelectronic devices This news ...

Scent marking

2013-10-31
Scent marking The mammalian equivalent of showy plumage Many animals use scent marking to advertise their territory – they urinate at strategic locations – to communicate their social status and ownership. It has ...

Research identifies ways to improve access to mental health services

2013-10-31
Research identifies ways to improve access to mental health services A study by researchers from the Universities of Liverpool and Manchester has identified ways to improve how older people and ethnic minority populations access mental health care services. As ...

Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant

2013-10-31
Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant DETROIT – New drug therapies offer promise to some hepatitis C sufferers whose transplanted livers are threated by a recurrence of the disease, including some ...

LAST 30 PRESS RELEASES:

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

A borrowed bacterial gene allowed some marine diatoms to live on a seaweed diet

Balance between two competing nerve proteins deters symptoms of autism in mice

Use of antifungals in agriculture may increase resistance in an infectious yeast

Awareness grows of cancer risk from alcohol consumption, survey finds

The experts that can outsmart optical illusions

Pregnancy may reduce long COVID risk

Scientists uncover novel immune mechanism in wheat tandem kinase

Three University of Virginia Engineering faculty elected as AAAS Fellows

Unintentional drug overdoses take a toll across the U.S. unequally, study finds

[Press-News.org] Researchers model familial amyloidosis in vitro using iPSC technology